Position | PhosphoPeptide | Catalytic kinase | Source |
---|
Y67 | AEAMNyEGSPI | Nucleoplasmin | PhosphoSitePlus |
S10 | MDMDMsPLRPQ | | PhosphoSitePlus; HPRD; phosphoELM; RegPhos |
T237 | EKTPKtPKGPS | CDK1 | HPRD; phosphoELM; SysPTM |
S4 | MEDSMdMDM | | RegPhos |
S227 | SKGQEsFKKQE | | HPRD; RegPhos |
T199 | KSIRDtPAKNA | CDK2 | HPRD; RegPhos; SysPTM |
S139 | KLLSIsGKRSA | Nucleoplasmin; DUF4366; T | PhosphoSitePlus |
S4 | MEDSMdMDM | PLK1 | RegPhos |
S217 | KDSKPsSTPRS | | HPRD |
T199 | KSIRDtPAKNA | CDC2(CDK1 | RegPhos; SysPTM |
S88 | VQPTVsLGGFE | | HPRD; phosphoELM |
S243 | PKGPSsVEDIK | TFIIF_alpha; Nop14 | PhosphoSitePlus |
T234 | KKQEKtPKTPK | | HPRD; phosphoELM; RegPhos |
Y17 | LRPQNyLFGCE | | HPRD |
S106 | RLKCGsGPVHI | | HPRD; RegPhos |
S227 | SKGQEsFKKQE | PKC_group | phosphoELM; RegPhos |
T234 | KKQEKtPKTPK | CDK1 | HPRD; phosphoELM |
S217 | KDSKPsSTPRS | TFIIF_alpha; Nop14 | PhosphoSitePlus |
S137 | DVKLLsISGKR | | HPRD; phosphoELM; RegPhos; SysPTM |
S70 | MNYEGsPIKVT | Nucleoplasmin | PhosphoSitePlus; SysPTM |
S254 | AKMQAsIEK | | HPRD; SysPTM |
T219 | SKPSStPRSKG | CDC2 | RegPhos |
T250 | NCFRMtDQEAI | | HPRD |
T237 | EKTPKtPKGPS | TFIIF_alpha; Nop14 | PhosphoSitePlus; SysPTM |
S242 | TPKGPsSVEDI | | HPRD |
S112 | GPVHIsGQHLV | | HPRD |
S254 | AKMQAsIEKGG | | HPRD; phosphoELM; RegPhos; SysPTM |
T78 | KVTLAtLKMSV | | HPRD; phosphoELM |
S222 | SSTPRsKGQES | TFIIF_alpha; Nop14 | PhosphoSitePlus |
S214 | PKGPSsVEDIK | | HPRD |
S231 | IEKGGsLPKVE | | HPRD |
T237 | EKTPKtPKGPS | | HPRD; phosphoELM; RegPhos; SysPTM |
S254 | AKMQAsIEKGG | TFIIF_alpha; Nop14 | PhosphoSitePlus; SysPTM |
S260 | IEKGGsLPKVE | TFIIF_alpha | PhosphoSitePlus; SysPTM |
S139 | KLLSIsGKRSA | | HPRD; phosphoELM |
T219 | SKPSStPRSKG | TFIIF_alpha; Nop14 | PhosphoSitePlus |
T219 | SKPSStPRSKG | | HPRD; phosphoELM; RegPhos |
S218 | DSKPSsTPRSK | | HPRD |
T199 | KSIRDtPAKNA | CDK1 | phosphoELM; SysPTM |
S88 | VQPTVsLGGFE | Nucleoplasmin | PhosphoSitePlus |
S222 | SSTPRsKGQES | | HPRD |
S4 | DMDM | | HPRD; phosphoELM |
T75 | SPIKVtLATLK | Nucleoplasmin | PhosphoSitePlus |
S143 | ISGKRsAPGGG | Nucleoplasmin; DUF4366; T | PhosphoSitePlus |
S112 | GPVHIsGQHLV | Nucleoplasmin; DUF4366; T | PhosphoSitePlus |
T95 | GGFEItPPVVL | Nucleoplasmin; DUF4366 | PhosphoSitePlus |
S293 | WQWRKsL____ | | PhosphoSitePlus |
T75 | SPIKVtLATLK | | HPRD; phosphoELM; RegPhos |
S70 | MNYEGsPIKVT | | HPRD; phosphoELM; RegPhos; SysPTM |
S214 | QNGKDsKPSST | TFIIF_alpha; Nop14 | PhosphoSitePlus |
S4 | __MEDsMDMDM | | PhosphoSitePlus |
S43 | NEHQLsLRTVS | | HPRD |
S243 | PKGPSsVEDIK | | HPRD; phosphoELM |
T46 | QLSLRtVSLGA | | HPRD |
S106 | RLKCGsGPVHI | Nucleoplasmin; DUF4366 | PhosphoSitePlus |
S4 | DMDM | PLK1 | HPRD; phosphoELM |
S218 | DSKPSsTPRSK | TFIIF_alpha; Nop14 | PhosphoSitePlus |
Y29 | KADKDyHFKVD | Nucleoplasmin | PhosphoSitePlus |
S225 | AKMQAsIEKGG | | HPRD |
S137 | DVKLLsISGKR | Nucleoplasmin; DUF4366; T | PhosphoSitePlus; SysPTM |
S227 | SKGQEsFKKQE | TFIIF_alpha; Nop14 | PhosphoSitePlus |
T199 | KSIRDtPAKNA | TFIIF_alpha; Nop14 | PhosphoSitePlus; SysPTM |
S198 | KKGQEsFKKQE | | HPRD |
T234 | KKQEKtPKTPK | CDC2(CDK1 | RegPhos |
T237 | EKTPKtPKGPS | CDC2 | RegPhos; SysPTM |
T208 | EKTPKtPKGPS | CDK1 | HPRD |
T279 | NCFRMtDQEAI | TFIIF_alpha | PhosphoSitePlus |
T78 | KVTLAtLKMSV | Nucleoplasmin | PhosphoSitePlus |
Y67 | AEAMNyEGSPI | | HPRD; phosphoELM |
S195 | APVKKsIRDTP | | HPRD |
S195 | APVKKsIRDTP | Nucleoplasmin; TFIIF_alph | PhosphoSitePlus |
T234 | KKQEKtPKTPK | TFIIF_alpha; Nop14 | PhosphoSitePlus |
Y17 | LRPQNyLFGCE | Nucleoplasmin | PhosphoSitePlus |
S213 | TPKGPsSVEDI | | HPRD |
T237 | EKTPKtPKGPS | CDC2(CDK1 | RegPhos; SysPTM |
T95 | GGFEItPPVVL | | HPRD; phosphoELM; RegPhos |
T279 | NCFRMtDQEAI | | HPRD; phosphoELM |
S125 | EEDAEsEDEEE | Nucleoplasmin; DUF4366; T | PhosphoSitePlus; SysPTM |
T234 | KKQEKtPKTPK | CDC2 | RegPhos |
S242 | TPKGPsSVEDI | TFIIF_alpha; Nop14 | PhosphoSitePlus |
S125 | EEDAEsEDEEE | | HPRD; phosphoELM; RegPhos; SysPTM |
T205 | KKQEKtPKTPK | CDK1 | HPRD |
S260 | IEKGGsLPKVE | | HPRD; phosphoELM; RegPhos; SysPTM |
T219 | SKPSStPRSKG | CDK1 | HPRD |
T199 | KSIRDtPAKNA | | HPRD; phosphoELM; RegPhos; SysPTM |
|
Ensembl ID | Cancer name | Design | Sample | Change | Ratio | Pubmed |
---|
ENSP00000296930 | Uterine Cancer | Normal vs. Cancer | tissue | Up | | 17902640 |
ENSP00000296930 | Hepatocellular Carcinoma | Normal vs. Cancer | tissue | Up | 3 | 17627933 |
ENSP00000296930 | Prostate Cancer | Metastasis | cell line | Up | 1.7 | 18232632 |
ENSP00000296930 | Prostate Cancer | Metastasis | tissue | Up | 3 | 18553995 |
ENSP00000296930 | Oral Premalignant Lesions | Normal vs. Cancer | tissue | Up | 1.2 | 19072117 |
ENSP00000296930 | Oral Premalignant Lesions | Normal vs. Cancer | tissue | Down | 0.96 | 19072117 |
ENSP00000296930 | Oral Premalignant Lesions | Normal vs. Cancer | tissue | Up | 1.6 | 19072117 |
ENSP00000296930 | Oral Premalignant Lesions | Normal vs. Cancer | tissue | Up | 1.7 | 19072117 |
ENSP00000296930 | Breast Cancer | Normal vs. Cancer | cell line | Up | 2 | 14997480 |
ENSP00000296930 | Breast Cancer | Treatment (none vs. multidrug resistant) | cell line | Down | 0.59 | 16540677 |
ENSP00000296930 | Breast Cancer | Metastasis | tissue | Up | 1.2 | 18416831 |
ENSP00000296930 | Hepatocellular Carcinoma | Normal vs. Cancer | tissue | Up | | 11866469 |
ENSP00000296930 | hepatitis B virus | Normal vs. Cancer | tissue | Up | 6.9 | 14654528 |
ENSP00000296930 | hepatitis C virus | Normal vs. Cancer | tissue | Up | 6.9 | 14654528 |
ENSP00000296930 | Hepatocellular Carcinoma | Normal vs. Cancer | tissue | Up | 6.9 | 14654528 |
ENSP00000296930 | hepatitis C virus | Normal vs. Cancer | tissue | Up | 3.3 | 16097030 |
ENSP00000296930 | hepatitis B virus | Normal vs. Cancer | cell line | Up | 3.9 | 19187611 |
ENSP00000296930 | Colorectal Cancer | Treatment (none vs transfected with HPV-16 E6 gene) | cell line | Down | | 15684709 |
ENSP00000296930 | Non-small cell lung carcinoma | Metastasis | cell line | Down | 0.29 | 17418446 |
ENSP00000296930 | Non-small cell lung carcinoma | Treatment (none vs CIGB-300 treatment) | cell line | Up | 11 | 20804217 |
ENSP00000296930 | Gastric Cancer | Treatment (none vs. Vincristine-resistant) | cell line | Up | 1.7 | 18253933 |
ENSP00000296930 | Breast Cancer | Metastasis | cell line | Down | 0.64 | 18582095 |
ENSP00000296930 | Breast Cancer | Metastasis | cell line | Down | 0.65 | 18582095 |
ENSP00000296930 | Breast Cancer | Metastasis | cell line | Down | 0.74 | 18582095 |
ENSP00000296930 | Breast Cancer | Normal vs. Cancer | tissue | Up | | 20560667 |
ENSP00000296930 | Testicular Cancer | Normal vs. Cancer | cell line | Up | | 18489135 |
ENSP00000296930 | Gastric Cancer | Treatment (none vs. hexamethylene bisacetamide (HMBA) treatment) | cell line | Down | | 20440860 |
ENSP00000296930 | Hepatocellular Carcinoma | Normal vs. Cancer | tissue | Up | | 11866469 |
|